Globe Life Sets 2026 Earnings Guidance At $15.35 To $15.65 A Share, Blaming Evry And Medicare Claims

The insurer also raised its 2026 buyback plan to $725 million to $775 million and gave a 2027 range of $16.10 to $17.10.

Share
Globe Life Sets 2026 Earnings Guidance At $15.35 To $15.65 A Share, Blaming Evry And Medicare Claims

Globe Life adjusted its full-year 2026 earnings guidance to $15.35 to $15.65 per share, pointing to two problems at its United American General Agency division, according to its third-quarter results release furnished with an 8-K on Wednesday. The company said the cause was those two items, "rather than a fundamental change in our underlying core business."

What the results show

Net income was $4.62 per diluted share in the third quarter, against $4.73 a year earlier. Net operating income, the company's measure that strips out items such as realized investment gains and losses, was $4.84, against $4.81.

Total premium revenue rose 7% to $1.31 billion. Health premium grew 16% and life premium grew 2%.

At United American, health underwriting margin was a loss of $6.4 million, against a $16.1 million margin a year earlier. The release says the loss was due primarily to an underwriting loss of about $16 million at Evry and a claims processing delay at the Centers for Medicare and Medicaid Services that produced about $7 million of excess prior-period Medicare Supplement claims. United American health premium still grew 29% to $219.3 million.

The guidance and the buyback

The company described Evry as a developing group health business still growing toward a size that will produce stable results. It tied the guidance change to high-severity claims at Evry and the Medicare claims delay. The release does not state the prior 2026 range.

For 2027, Globe Life estimates net operating income of $16.10 to $17.10 per share, which it said is an increase of 7.1% at the midpoint.

It bought back 1.1 million shares for $185 million in the quarter, at an average price of $175.61. It now expects to spend $725 million to $775 million on repurchases in 2026, compared with prior guidance of $670 million to $700 million.

The annual reserve update

Globe Life updates its reserve assumptions each third quarter, and the change runs through results as a one-time remeasurement. This year's update produced a pretax gain of $120.5 million, against $134.3 million a year ago, so year-over-year comparisons are partly shaped by it.

The company will hold its earnings call with financial analysts at 11:00 a.m. ET on Thursday.

Management's 2027 range of $16.10 to $17.10 per share is the number the Thursday call will test against these two claims problems.

Sources

More on Globe Life

All Globe Life (GL) coverage →